M. Delgado

Antibacterial agents based on the cyclic d,l-α-peptide architecture

Juan R. Granja, M. Ghadiri, J. Granja, 2001, Nature.

Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury.

Y. Satoh, B. Bennett, D. Giegel, 2012, Bioorganic & medicinal chemistry letters.

Spleen tyrosine kinase promotes acute neutrophil-mediated glomerular injury via activation of JNK and p38 MAPK in rat nephrotoxic serum nephritis

K. Blease, D. Nikolic-Paterson, F. Ma, 2011, Laboratory Investigation.

Antibacterial agents based on the cyclic D,L-alpha-peptide architecture.

M. Ghadiri, H. Kim, J. Granja, 2001, Nature.

Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor.

Philip Chamberlain, Y. Satoh, B. Bennett, 2012, Bioorganic & medicinal chemistry letters.

Discovery of the c-Jun N-Terminal Kinase Inhibitor CC-90001.

Y. Satoh, B. Bennett, D. Mortensen, 2021, Journal of medicinal chemistry.

Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005.

E. Hur, Lisa Morrison, B. Bennett, 2021, Journal of medicinal chemistry.

A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation

K. Miyazawa, B. Bennett, L. LeBrun, 2016, PloS one.